Consultant Urological Surgeon

Mr Chris Blick

MBChB DPhil FRCS(Urol)

MEMBERSHIPS

Fellow of the Royal College of Surgeons of England

Member of British Association of Urological Surgeons

Doctor of Philosophy (DPhil.) Christ Church Oxford

Year Qualified: 2002

AREAS OF EXPERTISE

Minimally invasive and robotic surgery for benign and malignant kidney and bladder conditions
Management of urological cancers
Treatment for Benign Prostatic Enlargement including UroLift & Rezum
Investigation of blood in the urine or semen
General urological conditions effecting the male and female urinary tract
Urinary tract Infections
Treatment of PUJ obstruction
Treatment of Male urinary tract symptoms
Transperineal Fusion Prostate Biopsies
Management of prostatitis

Academic Background

Chris Blick Consultant Urologist Mr Chris Blick carried out his specialist urological training in the Oxford deanery within the hospitals of Oxfordshire, Berkshire, and Buckinghamshire. He completed his specialist training with a British Association of Urological Surgeons Fellowship to the Keck Institute of Medicine, University of Southern California, USA. This was under the tutorship of Professor Inderbir Gill, a world renowned pioneer and international leader of robotic renal and bladder surgery. His team has the world’s most extensive experience of robotic renal and bladder surgery having carried out over 13,000 procedures.

Prior to specialist training, Mr Chris Blick was awarded competitive fellowship grants by The Royal College of Surgeons, The Urology Foundation and UCare. This supported 3 years of full time laboratory based scientific research in kidney and bladder cancer. Following this, Mr Chris Blick has published extensively in the clinical and scientific literature on kidney and bladder cancer and after completing his thesis was awarded a DPhil (PhD) by Christ Church, University of Oxford.

During specialist training, Mr Chris Blick was elected by his peers as Chairman of the Specialist Urology Registrars Group (SURG). Mr Blick represented the views and educational needs of all the UK and Irish specialist urological trainees / residents over the 3 years of his chairmanship.

Professional Profile

Mr Chris Blick is a Consultant Urological Surgeon who has a subspeciality interest in urological cancers, particularly laparoscopic and robotic renal, ureteric and bladder surgery.

Mr Blick has an interest in the treatment of benign prostatic enlargement using rezum and urolift technology.

Mr Chris Blick also has a particular interest in clinical trials. He was successful in becoming the first urological trainee member of the National Institute of Heath Research (NIHR) clinical studies group (CSG). He currently sits on the national renal and bladder cancer CSG, the screening and early prevention (SPED) group and the UK cancer screening and early prevention group of the NIHR.

He is the Research and Development Lead in Urology at the Royal Berkshire Hospital. He has recently received funding and is Chief Investigator in the TARGET trial using augmented reality and artificial intelligence in the diagnosis of prostate cancer. He is also UK Chief Investigator for the EASE Trial examining the role of active surveillance in renal cancer.

Specialisms

Rezum

Valentina

Valentina Dakpogan

0118 920 7040
valentina.dakpogan@theforburyclinic.co.uk

Insured patients

Contact your GP and ask for a referral to the Urology Partnership.

All consultations, investigations and treatments are covered by major insurance companies (depending on policy).

Funding your own treatment

Self-funding initial consultation fee is £205. Follow up fees are £165.

Consultation charges are exclusive of any tests and other investigations that the consultant may wish to carry out.

Make an Appointment with Mr Chris Blick

If you are making an appointment on behalf of someone else, please complete the form with their details but add your own name and contact details into the "further information" box.

* Denotes a required field





We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.